Pozen's Vimovo approved in U.K.

The U.K. approved Vimovo (formerly PN 400) from Pozen Inc. (NASDAQ:POZN) to treat signs and symptoms of osteoarthritis, rheumatoid arthritis (RA) and ankylosing spondylitis, and to decrease the risk o...